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Human female reproductive biology is a complex system and its pathologies are 
varied. However, majority of the pathologic processes involves the role of reactive 
oxygen species (ROS). Imbalance between the ROS and antioxidants results in oxi-
dative stress (OS). OS is the pathognomonic factor in various female reproductive 
system ailments. OS contributes to the pathophysiology of infertility, pregnancy 
related complications, endometriosis, ovarian cancers, etc. Evidence of elevated 
oxidative stress biomarkers can be found in various inflammatory conditions. 
Numerous strategies have been postulated for management of OS related pathologic 
conditions. Antioxidants supplementation may play a crucial in prevention and 
management of these conditions. However, robust evidence is needed to support 
the role of antioxidants supplementation in various female reproductive disorders.
Keywords: free radicals, oxidative stress, cellular damage, antioxidants, female 
reproductive tract diseases
1. Introduction
Oxygen is vital for sustaining life. However, its damaging effect on living cells 
through production of reactive oxygen species is a paradox of cell metabolism [1]. 
These free radicals with unpaired electrons are toxins that are produced as the body 
cells uses oxygen to sustain for processing food or reacting to the environment. 
They have damaging effect through adverse reactions to various components of 
the cell [2].
Antioxidants also called “free-radical scavengers”, are biological and chemical sub-
stances that fights the damage to cells caused by free radicals produced in our body. 
These are metabolites and enzymes that either prevent formation of free radicals or 
clear them from the body before they exert harmful effects on the integral compo-
nents of cell such as DNA, proteins and lipids [1, 3]. Ineffective elimination of free 
radicals leads to oxidative stress. Oxidative stress is the pathognomonic factor in vari-
ous female reproductive system ailments. Diverse effects of free radicals on female 
reproductive system are subject to location, concentration and the extent of exposure 
to these molecules [4]. Oxidative stress can affect manifold physiological mecha-
nisms such as oocyte maturation, fertilization, implantation, embryo development 
and hence contributes to the pathophysiology of pregnancy related complications, 
endometriosis, polycystic ovarian disease, unexplained infertility and gynecological 
cancers [5]. The objective of this chapter is to discuss the influence of antioxidants in 
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different physiological processes to maintain healthy female reproductive function 
and their role in the prevention of various diseases of the female genital tract.
2. Free radicals
Free radicals are products of normal cellular metabolism with an unpaired 
electron which makes them highly reactive and unstable [6, 7]. They have high 
tendency to react with other molecules to initiate a chain of reactions resulting 
in cellular damage and disease [8]. They are mainly of two types: reactive oxygen 
 species (ROS) and reactive nitrogen species (RNS).
2.1 Reactive oxygen species
Reactive oxygen species (ROS) comprise of mainly three types: (a) superoxide 
anion (O2
−), (b) hydrogen peroxide (H2O2), and (c) hydroxyl radical (HO•) pro-
duced due to partial reduction of oxygen [8]. Endogenous sources of free radicals 
and other ROS in the body originate from the basic reactions of metabolism essen-
tial for sustenance of life while exogenous sources are essentially due to hazardous 
exposure to X-rays, ozone, cigarette smoking, air pollutants, certain drugs and 
pesticides, and industrial chemicals [9]. Origin of endogenous free radicals may be 
from: mitochondria, xanthine oxidase, peroxisomes, inflammation, phagocytosis, 
arachidonate pathways, exercise, ischemia/reperfusion injury [10]. Enzymatic and 
nonenzymatic reactions both give rise to free radicals in the body. Most of enzy-
matic reactions occur in respiratory chain, phagocytosis, prostaglandin synthesis 
and cytochrome P-450 system [11] while nonenzymatic reactions are those of 
oxygen with organic compounds and ionizing reactions [12].
ROS have been associated with a number of diseases of female reproductive tract 
as their presence in ovaries, [13–17], fallopian tubes [18] and embryos [19] have 
been established in various animal and human studies. ROS has been implicated 
in the regulation of integral functioning of female reproductive organs viz. oocyte 
maturation, ovarian steroidogenesis, embryo metabolism, corpus luteal function 
and luteolysis [13, 14, 20].
ROS are formed from normal cellular metabolism and comprises of oxygen ions, 
free radicals and peroxides. They take part in chemical reactions that remove their 
unpaired electron. Either an increase in levels of ROS or a decline in the antioxidant 
defence system of cells causes oxidative stress that induces direct or indirect ROS-
mediated macro molecular damage of nucleic acids, proteins, and lipids. This has 
significant implications in pathogenesis of carcinogenesis [21], neurodegeneration 
[22, 23], atherosclerosis, diabetes [24], and aging [25]. ROS is assumed to regulate 
signalling of cellular pathways by which it may contribute to tumour metastasis 
by gene activation [26]. The knowledge of chemo-interactive processes occurring 
between the ROS and various molecules involved in the cellular signalling pathways 
is crucial for understanding the pathogenesis of oxidative stress. Redox reaction 
between different protein residues and the ROS is the core component of this 
chemo-interactive process. This redox reaction results in the oxidation of cysteine 
residues on proteins to form reactive sulfenic acid (−SOH). Further oxidation of 
sulfenic acid (−SOH) results in the formation of sulfinic (−SO2H) or sulfonic  
(−SO3H) acid or sulfenamide (in presence of nitrogen). Oxidation of these protein 
components results in various ultrastructural changes and/or functional alteration. 
Some of these alterations are reversible with the aid of antioxidant defence mecha-
nism viz. thioredoxin pathways but rest of the alteration especially involving the 
generation of sulfonic acid results in permanent damage [2].
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2.2 Reactive nitrogen species (RNS)
Nitric oxide–derived compounds, which includes nitroxyl anion, nitrosonium 
cation, higher oxides of nitrogen, S-nitrosothiols, and dinitrosyl iron complexes are 
reactive nitrogen species (RNS). RNS are considered to modulate the physiologic 
processes of many living cells which may include smooth muscle cells, cardio-
myocytes, platelets, and nervous and juxtaglomerular cells. Nitric oxide (NO) is 
formed when L-arginine is converted to L-citrulline by nitric oxide synthase (NOS) 
[27–29]. NO plays a vital role in modulating diverse physiological mechanisms 
such as relaxation of arterial and venous smooth muscles and inhibition of platelet 
 aggregation but excess of NO may not have favourable consequences [28, 30]. 
NO with an unpaired electron is highly reactive and can induce harmful effects to 
proteins, carbohydrates, nucleotides and lipids. Along with synergistic effects from 
other mediators of inflammation, this free radical can cause tissue damage, inflam-
mation and adhesions by inducing nitrosative stress [28].
Nitrosative stress has been linked to inflammatory vascular disease in pregnant 
women such as preeclampsia where the pathognomonic features include hyperten-
sion along with generalized endothelial dysfunction, proteinuria, and foetal growth 
restriction [31]. There is surge in production of nitric oxide due to vascular inflam-
mation induced by shed membrane particles of leukocytes and platelets along with 
elevated levels of microparticles from plasma membrane of apoptotic or activated 
circulating cells or cells of the vascular wall [32, 33] resulting in generation of pro-
inflammatory proteins. Platelet microparticles more precisely are pro-inflammatory 
and hence contribute markedly for nitrosative stress in the vascular wall [34].
3. Antioxidants
To combat the adverse effect of oxidative stress, human body has evolved vari-
ous defense mechanisms viz. preventive and repair mechanisms, physical defenses, 
and antioxidant system. Antioxidants can be chemically described as any molecule 
that can donate electron/s or act as a reducing agent in a redox reaction resulting 
in conversion of a reactive molecule in to a relatively stable and inert substances. 
Antioxidants by its virtue as an electron donor can react with ROS, resulting in sup-
pression of oxidative stress [35]. However, this simple way to describe “antioxidants” 
cannot be justified and it has much wider connotations and complexity. The ability 
of a molecule to participate in a redox reaction with a ROS is not only the distinguish-
ing feature for an antioxidant. There are numerous molecules which can interact with 
a ROS resulting from the modulation of inflammatory cascades. Inhibitor molecules 
for NADPH oxidase and lipoxygenases as well as cofactors for antioxidant enzymes, 
and metal chelators which can negate the ROS levels, can also be termed as antioxi-
dants. However, it should be remembered that in an appropriate environment, many 
of these antioxidants may function as a prooxidant due the inherited redox potential 
of these substances [36, 37]. Hence, proper understanding of these diverse molecules 
is critically needed prior to formulating rational antioxidant therapies. Antioxidants 
can broadly be classified as enzymatic and non-enzymatic as depicted in Table 1.
Antioxidants, both endogenous and exogenous in origin, counteracts free 
radicals mediated injury in an interactive and synergistical ways (Table 2) [38].
3.1 Enzymatic antioxidants
Enzymatic antioxidants are endogenously synthesized molecules and are more 
efficacious as free radical scavenging role. These antioxidants have transition 
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metal core which are capable of transfer of electrons essential for redox reaction 
with ROS and thereby, effectively neutralizing the adverse effects of ROS. These 
endogenously produced enzymes include superoxide dismutase enzymes (SODs), 
glutathione peroxidase, catalases, and glutathione oxidase.
Superoxide dismutase: SOD is an enzyme system that catalyzes the of the super-
oxide (O2−) radical into ordinary molecular oxygen (O2) and hydrogen peroxide 
(H2O2). SODs are group of metalloproteins and its enzymatic functions were 
first discovered by Irwin Fridovich and Joe McCord at Duke University in 1968 
[39]. There are various isoforms of this enzyme but in humans, it exists mainly 
in three isoforms viz. SOD1, SOD2 and SOD3. SOD1 is located in the cytoplasm, 
SOD2 is predominantly found in the mitochondria, and SOD3 is extracellular. 
The genes are located on chromosomes 21, 6, and 4, respectively (21q22.1, 6q25.3 
and 4p15.3-p15.1). SOD1 is a dimer, whereas SOD2 and SOD3 are tetramers. SOD1 
contains a core of two metal cofactors comprising of copper (Cu) and zinc (Zn). 
Mitochondrial SOD2 contains manganese and is encoded by nuclear DNA. SOD3, 
the extracellular enzyme, Cu-Zn has in its reactive center.
ROS Neutralizing antioxidants
Hydroxyl radical Vitamin C, Glutathione, Flavonoids, Lipoic acid
Superoxide radical Vitamin C, Glutathione, Flavonoids, Superoxide dismutase
Hydrogen peroxide Vitamin C, Glutathione, beta carotene, Vitamin-E, flavonoids, lipoic acid
Lipid peroxides Beta-carotene, Vitamin-E, Ubiquinone, flavonoids, Glutathione peroxidase
Table 2. 
ROS and Neutralizing Antioxidants.
Enzymatic antioxidants Non-enzymatic antioxidants
Superoxide dismutases (SOD) a. Endogenous Antioxidants
Peroxidases • Bilirubin
Catalases • Uric acid
Thioredoxin (Trx) system • NADPH and NADH
• Thiols, e.g., glutathione, N-acetyl cysteine
• Ubiquinone
b. Dietary Antioxidants & micronutrients
• Vitamin A, C, E and the B complex, Zinc, Selenium
• Beta carotene and other carotenoids
• Polyphenols, e.g., flavonoids, flavones
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Glutathione peroxidase: It belongs to a large class of enzyme system called 
peroxidases. The primary biochemical function of glutathione peroxidase (GPx) 
is the conversion of lipid hydroperoxides to their corresponding alcohols and to 
reduce free hydrogen peroxide to water, which is the crucial function as an anti-
oxidant. GPx exists in eight different isoforms in humans and contains selenium 
as its reactive core. It is a tetrameric enzyme with the exception of GPx4 which is a 
monomeric enzyme.
Catalases: It is an iron containing enzyme which catalyzes the biotransformation 
of hydrogen peroxide to non-reactive water and oxygen.
Apart from these endogenous enzymatic antioxidants, thioredoxin plays a 
central role in humans as a defensive response to ROS. They act as antioxidants by 
facilitating the reduction of other proteins by cysteine thiol-disulfide exchange. 
They also play an important role in cell survival [40].
3.2 Nonenzymatic antioxidants
Nonenzymatic antioxidants comprises of various exogenous dietary nutrients 
as well as endogenous compounds. They may act directly as an antioxidant or as an 
adjuvant to others molecules which participates in redox reaction.
Vitamin C and vitamin E plays a central role as defense mechanism against 
ROS. They act synergistically as a redox buffer to reduce the impact of oxidative 
stress imposed by various ROS. Vitamin C neutralizes superoxide radicals as well 
as other singlet oxygen species. Vitamin E is a potent scavenger of peroxyl radi-
cals. α-tocopherol has the most potent antioxidant capabilities compared to other 
tocopherols due to the fact that H+ donating ability of different tocols increases in 
efficiency with greater ring methyl substitution. Thiols like glutathione is another 
endogenous antioxidant found in humans and is also can be found in oocytes 
and embryos in abundant amount. They exert their effect by virtue of its thiol 
component of cysteine residue which take part in the redox reaction. Moreover, 
glutathione can act as a cofactor for several antioxidant enzymes viz. glutathione 
peroxidase (GPx) and glutathione transferase [41]. Various micronutrients like Zn, 
Se, Cu aids the enzymatic antioxidants to counter the ill-effects of OS. Metal bind-
ing proteins like transferrin and ceruloplasmin combines with free iron ions which 
is a vital component of redox reaction (Fenton). Bilirubin is a tetrapyrrole pigment 
which possesses potent antioxidant and anti-inflammatory properties. This remark-
able antioxidant activity appears likely to stem largely from the inhibitory action 
of unconjugated bilirubin over common isoforms of NADPH oxidase, which is an 
active participant of superoxide-generating reactions [42–44]. Another endogenous 
molecule bearing potent antioxidant property is uric acid. Uric acid is an efficient 
oxygen radical scavenger. At physiological concentrations, urate reduces the oxo-
heme oxidant formed by peroxide reaction with hemoglobin, thereby, protecting 
the erythrocytes from lysis due to lipid peroxidation.
4. Female reproductive diseases
The prooxidants and antioxidants work in synchrony to maintain a balance in 
the milieu of cellular metabolism. When this mechanism fails, oxidative stress is the 
sequelae. Prooxidant generation is influenced by cyto- chrome P450, and the corpus 
luteum is presumed to be one of its key sources [45]. The crucial role of free radicals 
in regulating the various physiological reproductive processes renders its influence 
on the oocytes, sperm, and embryos and their microenvironments. These changes 
in microenvironment has a direct bearing on follicular fluid, hydro salpingeal fluid, 
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and peritoneal fluid which substantially determine the oocytes quality, interaction 
between sperm and oocyte, implantation of embryo and its early development 
[46–48]. Hence oxidative stress can affect the prospects of a favourable pregnancy 
and is also attributed to pathophysiology of endometriosis, hydrosalpinges, poly-
cystic ovary syndrome (PCOS), and unexplained subfertility [49].
4.1 Female subfertility
World Health Organization (WHO) defines Infertility or subfertility as the 
“failure to achieve a clinical pregnancy after 12 months or more of regular unpro-
tected sexual intercourse” [50]. With 48.5 million couples infertile globally [51], it is 
a health concern spread worldwide in which female factors are assumed to contrib-
ute to 40–50% percent of cases [52, 53]. Ovulatory dysfunction, tubal and pelvic 
pathology, endometriosis, and poor egg quality are among the most common causes 
of female subfertility while reproductive age and body mass index (BMI) are vital 
demographic determinants [54]. Notwithstanding the evidence of obvious patholo-
gies, role of toxic products produced during oxidative stress in the occurrence of 
female subfertility is well established [55, 56].
ROS however has dual role. It may serve as key modulating agent in numerous 
physiological processes while in excess may cause cellular damage. The equivalence in 
the body is maintained by appropriate levels of antioxidants and hence determining 
the levels of the antioxidants as total antioxidant capacity (TAC) has been investigated 
in many studies [57–59]. Ovulation is one of key physiologic process in female that 
is evidenced by high numbers of macrophages and neutrophilic granulocytes in the 
follicle wall along with fast metabolism of granulosa cells. This gives high probability 
of ROS generation which may be essential for oocyte development and consequent 
progression to embryo. ROS are assumed to influence oocyte maturation [60] lute-
olysis [61, 62] progesterone secretion by the corpus luteum [63, 64] ovulation and 
follicular atresia [65]. ROS are linked to single follicle generation by stimulating atretic 
regression of the cohort of newly grown follicles through its action on granulosa cells 
to exhaust its reactivity to gonadotrophic hormones and steroidogenic function [65]. 
Pasqualotto et al. [66] found positive correlation of lipid peroxidation (LPO) and total 
antioxidant capacity (TAC) in pooled FF to pregnancy rate hence concluding high 
levels of LPO do promote oocyte and embryo development and enhance their quality.
Several studies have documented benefits of supplementary antioxidants in such 
cases with diverse methods of action. Vitamin E is assumed to improve epithelial 
growth in blood vessels and in the endometrium [67]. N- acetyl-cysteine improves 
cervical mucus for sperm penetration and also helps in ovulation [68]; L-arginine 
increases endometrial blood flow for successful implantation [69]; Myo-inositol 
improves ovarian function by decreasing levels of androgen and increasing sen-
sitivity to insulin [70] while PUFAs promotes prostaglandin and steroid hormone 
synthesis apart from contributing to formation of cell membranes of the sperm 
and oocyte essential for fertilisation [71]. Even in Assisted reproductive technol-
ogy, ROS may arise from cumulus cells, leucocytes, and culture media. Hence IVF 
cycles will yield better results if patients are screened for oxidative stress levels 
[72]. Culture medium are supplemented with antioxidants like β-mercaptoethanol, 
protein, vitamin E, vitamin C, cysteamine, cysteine, taurine and hypotaurine, 
and thiols to enhance the growth and maturation of embryos by downplaying the 
effects of ROS. ROS are scavenged by antioxidants and subsequently exert favour-
able effects by reducing blastocyst degeneration, embryo apoptosis and increasing 
hatching of blastocysts. Improvement of sperm morphology and preimplantation 
embryo development as well as reduction of developmental defects are reported 
with inclusion of antioxidants in the treatment protocol of infertile patients [73].
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4.2 Endometriosis
Endometriosis is defined as the presence of endometrial tissue outside of 
uterine cavity which lead to chronic inflammatory reaction [74]. It affects 6–10% 
of women in the general female population and is prevalent in 30–45% of patients 
with infertility or chronic pelvic pain [75, 76]. It is one of the most widespread 
gynaecological diseases and women present mostly with significant cyclic pelvic 
pain that escalate just prior to starting of menses and subside with onset of blood 
flow. In a few atypical cases, patients may not have any complaint and hence poses 
a dilemma for diagnosis [77]. This oestrogen dependent female pelvic pathology is 
mainly diagnosed by laparoscopy or laparotomy and confirmed by histopathologi-
cal examination of retrieved pelvic tissues [78].
There are innumerable theories of the pathophysiology of endometriosis. The 
origin of OS in endometriosis is assumed to be induced by apoptotic endometrial 
tissue which get implanted in peritoneal cavity through retrograde menstrua-
tion. This tissue along with menstrual effluent are assumed to be antigenic and 
activate macrophages. Consequently, the number and activity of macrophages in 
the peritoneal fluid (PF) increase that phagocytose antigens. This results in release 
of inflammatory cytokines such as interleukin (IL) 2, 4, 10, TNF-a and IFN-g 
[79, 80] and serum and peritoneal IL-33 in cases of deeply infiltrating endometrio-
sis [81]. Increased inflammatory activity is known to cause OS [82]. Apart from 
macrophages, there is upregulation of transcription factor NF-kB in endometriosis 
[83–85] which can activate many genes to further increase inflammation and 
promote progression of the disease [86]. ROS damage the fragile mesothelium thus 
facilitating adhesion and implantation of the endometrial cells to further promote 
progression of the disease [87]. Hence elevated Oxidative stress could be cause or 
a consequence of one of this debilitating diseases of females of reproductive age 
group [8].
Despite endometriosis being a disease with benign pathology, there are features 
in endometriosis identical to cancer such as the invasion of tissues, tendency to 
evade programmed cell death, distal spread and high propensity of angiogenesis. 
[88] which renders its close association to ROS reported in numerous studies 
[89, 90]. The essential feature of angiogenesis and immunity to apoptosis com-
mon to both endometriosis and tumorigenesis results in accelerated proliferation 
rate subsequently producing increased ROS. The pathogenesis of cellular dam-
age by ROS in both endometriosis and cancer cells is same. ROS acts as a second 
messenger of cell proliferation [91] by activating MAPK signalling pathways to 
accelerate cell proliferation. Hence this linkage between ROS and cell proliferation 
in cancer illustrates the definite role of elevated ROS in modulating cell prolifera-
tion in endometriosis. To elucidate the fact, NgÔ et al. [91] used purified stromal 
and epithelial cells from ovarian endometrioma and ectopic endometrium of 
endometriosis to create cell lines. The experiment showed endometriotic cells 
had high OS levels with increased ROS production and decreased catalase levels. 
There was increased cellular proliferation and activation of ERK1/2. A group 
of enzymes called MMPs also contribute to increase ROS in the pathogenesis of 
endometrial disease. MMPs facilitate implantation of ectopic endometrial cells 
by degrading the extracellular matrix of the peritoneal mesothelium [92]. Hence 
the recent strategies to reduce oxidative stress for effective treatment of endome-
triosis in preference to creating non-oestrogen environment by pharmacological 
intervention has been gaining evidence. Studies showed there is decrease in 
symptoms with antioxidant (vitamin E, vitamin C, zinc and selenium) intake [93] 
as well as improvement in antioxidant markers with antioxidant rich diet [94]. 
Aminoguanidine through OS reduction prevent adhesion to peritoneal surface. 
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There are a number of compounds that can act as antioxidants and can manifest 
its favourable effects in improving the symptoms of endometriosis.
Vitamin C is required for carrying out diverse physiological processes of the 
body. Humans and other primates acquire it from exogenous sources that acts as 
co-factor for a number of enzymes, most notably hydroxylases involved in collagen 
synthesis apart from being an effective antioxidant. Vitamin E is a lipid-soluble 
antioxidant that scavenges peroxyl radical to eliminate the effect of free radicals and 
get transformed to tocopheryl radical that is subsequently reduced by a hydrogen 
donor (as Vitamin C) to return to its reduced state [95].
Resveratrol is a natural polyphenolic flavonoid having antineoplastic, anti-
inflammatory and antioxidant properties [96]. It is synthesized by plants following 
exposure to ultraviolet radiation. Its anti-inflammatory effect is mediated through 
inhibition of cytokines (tumor necrosis factor-a, IL-6, IL-8), VEGF and monocyte 
chemotactic protein 1. It inhibits production of ROS by monocytes, macrophages 
and lymphocytes and regulate cell proliferation and apoptosis by inhibiting NF-kB 
[97]. It reduces VEGF levels to prevent angiogenesis [98]. Resveratrol is already 
used in the treatment of several clinical conditions such as cardiovascular diseases, 
cancer, type-2 diabetes mellitus and neurodegenerative diseases and is being 
explored for its impact in the treatment of endometriosis.
Melatonin is secreted by pineal gland predominantly during the night and has 
potent antioxidant effects. It is also shown to stimulate antioxidant enzymes [99]. 
It can induce down-regulation of MMPs. Hence its mode of action as antioxidant 
in endometriosis can range from scavenging toxic free radicals [100] to regulating 
levels of MMPs in ectopic and eutopic endometrial tissue [101, 102]. It can also act 
as antioxidant enzymes stimulator [99].
N-acetyl-L-cysteine (NAC) is another antioxidant which is precursor of gluta-
thione [103] and is found to inhibit proliferation of endometrial cells [104, 105]. 
It acts through its ability to limit tissue invasion [106] and suppression of NF-kB 
activation which acts as a transcriptional factor in the pathophysiology of endome-
triosis [107]. Its other mode of action is linked to activation of the immune system 
by increasing IL-2 levels and the expression of CD25 on T cells [107] apart from 
expression of membrane TNF-a expression [103].
Xanthohumol is extracted from Humulus lupulus (species of flowering plant of 
Cannabaceae) and has antioxidant and anti-inflammatory properties. Rudzitis-
Auth et al. suggested Xanthohumol if taken through dietary supplements is effec-
tive for selective treatment of endometriotic lesions [108]. It acts by inhibition of 
NF-kB signaling pathway [109] as well as decreasing production of NO by through 
suppressing of NO synthase [110].
Epigallocatechin-3-gallate (EGCG) is another antioxidant found in green tea 
which has also antimitotic and antiangiogenic properties [111]. The effect of EGCG 
on endometriosis is studied both in vitro and in vivo and is assumed to reduce OS 
by VEGF reduction and inhibition of angiogenesis. It also inhibits cell proliferation, 
migration and invasion of endometrial cells [112].
4.3 Pre-ecclampsia
Pre-ecclampsia involves gradual development of hypertension (systolic blood 
pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg), or deteriora-
tion of pre-existing hypertension, proteinuria (300 mg/L or more in 24 h), general-
ized oedema, and sometimes blood clotting disorders occurring after 20 weeks of 
gestation [113]. Severe preeclampsia may progress to eclampsia and the HELLP 
syndrome, which involves haemolysis, elevated liver enzymes and low platelets. The 
spectrum of these hypertensive disorders can impose serious foetal morbidity like 
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intrauterine growth restriction and preterm births which has further implications 
of early neonatal death and infant mortality. The pathophysiology of pre-eclampsia 
still remains a subject of research. The existing theories suggest incomplete cyto-
trophoblast invasion into the spiral arteries in the uterus that causes malformed 
placenta leading to deficient perfusion of placenta. Role of antiplatelet agents and 
calcium supplements to delay this process are being studied [114, 115]. This inad-
equate placental perfusion may induce OS with decline in concentrations of anti-
oxidants in plasma and placenta [116, 117]. This complemented with inflammatory 
response of body cause damage to endothelial cells resulting in signs and symptoms 
of pre-eclampsia. Antioxidants prevent oxidation of proteins and enzymes, destroy 
free radicals, and preserve the integrity of cellular membrane [118]. Hence dietary 
or therapeutic antioxidant supplements in women can possibly eliminate the delete-
rious effects of OS and uteroplacental endothelial damage evident in preeclampsia. 
A few recent meta-analysis however failed to show any beneficial role of antioxi-
dant therapy on prevention of PE [119, 120]. More trials are needed to establish the 
effect of antioxidants on pre-eclampsia and to provide evidence-based information 
on its adverse effects and long-term consequences on the growth and development 
of the children.
4.4 Peripheral neuropathy in obstetrics
Pregnant women are prone to a number of neuropathic syndromes due to 
physical changes resulting from enlargement of the uterus and the gradual growth 
of the foetus. The subsequential postural changes and nutation of the pelvic girdle 
and vertebrae due to high concentrations of relaxin released from the tenth week of 
gestation gives rise to low back pain and entrapment neuropathies. Analgesic drugs 
and surgery being contraindicated in pregnancy, the best approach to treat such 
morbidity in pregnancy remains a dilemma. Rehabilitation therapies and neuro-
protectors in such cases have proved effective in relieving pain and paraesthesia 
of peripheral neuropathies [121]. Role of antioxidants as neuroprotective agents 
are investigated lately. One of such agent is alpha-lipoic acid (ALA) which acts as 
a powerful antioxidant in the body. It exerts its functions in every cell and tissue 
in the body due to its solubility in both water and fat. This potent antioxidant can 
modulate many inflammatory pathways through its inhibitory effect on production 
of vascular and intracellular adhesion molecules (VCAM-1 and ICAM-1), reducing 
the expression of CD4 on blood mononuclear cells, secretion of tumour necrosis 
factor (TNF)-∝ and inhibition of natural killer (NK) cells [122]. It also has direct 
inhibitory action on the transcription factor NF-κB which regulates the expression 
of various genes associated with inflammatory response and cell apoptosis [123]. 
Hence supplementation with ALA by virtue of its antioxidant and anti-inflamma-
tory action has been shown to relieve pain and paraesthesia in patients with sciatica, 
carpal tunnel syndrome and diabetic neuropathy [124–127].
ALA supplementation at doses of up to 2400 mg/day and intravenous adminis-
tration of 600 mg/day seemed to be safe in humans [123]. The safety of this potent 
antioxidant in pregnant women are yet to be established, however several studies 
have credited its role in the prevention of premature rupture of membranes, threat-
ened miscarriage and gestational diabetes [128].
4.5 Gynecological (ovarian, endometrial and cervical) cancers
Gynaecological cancers present a diagnostic challenge in early stage since the 
symptoms appear mostly when the disease has metastasized. Two third cases are 
diagnosed in advanced stage accounting for high fatality-to-case ratio among all 
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malignancies in women [129]. The process of carcinogenesis occurs in multiple 
steps starting from normal cell to pre-cancerous stage and finally to an early stage 
of cancer [130]. A single cell undergoes sequential events in the form of initiation, 
promotion and progression to finally turn cancerous. ROS can act in all the three 
stages to stimulate carcinogenesis [131].
Initiation is the first stage of carcinogenesis and is executed as a consequence 
of an irreversible genetic alteration, that may be either simple mutations, trans-
versions, transitions, and/or small deletions in DNA. DNA damage by oxidation 
can also occur through hydroxyl radical produced from H2O2. Increased oxidative 
stress may deplete the endogenous antioxidant reserves and activate endonucleases 
resulting in DNA fragmentation [130]. The second stage of promotion is revers-
ible and it mediates promoter-receptor interactions to influence expression of the 
genome. Tumour promoters induce production of oxygen radical by modulating 
metabolic processes of cells. These oxygen radicals through modulation of gene 
associated with proliferation or cell death can induce the expression of mutated cell 
clones. However low levels of oxidative stress can promote cell division and tumour 
growth whereas high levels have cytotoxic effects and can hinder cell proliferation 
[131, 132]. In the ultimate stage of progression there is karyotypic instability and 
malignant growth. Progression is characterized by expeditious proliferation of cells, 
elusion from immune suppression, tissue invasion and metastasis [133]. Genesis of 
abundant free radicals along with increase in the level of oxidized DNA bases dur-
ing oxidative stress may incite some tumours to mutate, inhibit anti-proteases and 
cause damage to local tissues [134]. In fully developed cancer cells, these modified 
DNA bases may induce genetic instability and metastatic propensity [135].
Diverse natural substances have been recognised to have role in cancer preven-
tion [136] and treatment [137] when supplemented with chemotherapy, radio-
therapy, and surgery. The drugs used in radiotherapy and chemotherapy can cause 
diverse tissue and organ damage through generation of free radicals which can also 
induce carcinogenesis [138]. Several studies reported that using antioxidants with 
anticancer drug therapy can significantly decrease these cellular damages and is 
associated with reduced risk of all-cause mortality and recurrence risk [138, 139].
However, many natural antioxidants may depict conflicting properties in cancer 
cells. The actions vary according to their concentration. With the possibility of 
antioxidants causing direct damage to DNA and the cell, speculations are arising 
on the role of antioxidant in the causation of cancer [140]. Recent studies suggest 
supplementation of antioxidants in high doses may have ill effects on health. The 
association of high doses of beta- carotene with lung cancer in smokers and high 
doses of vitamin E with that of prostate cancer are some examples of health hazards 
of antioxidants [141].
Hence the biological characteristics of natural antioxidants are assumed being 
beneficial or harmful depending on their concentration. The natural substances 
exhibit their antioxidant potential in lower concentration by increasing the expres-
sion of ROS scavengers while higher concentration can generate oxidative stress.
4.6 Polycystic ovarian disease
Polycystic ovary syndrome (PCOS) is a major public health disorder affect-
ing 5–21% of women in reproductive age group. This most common endocrine 
disorder among reproductive-aged women has multitude of manifestations that 
includes reproductive (hyperandrogenism, hirsutism, anovulation, infertility, and 
menstrual disturbance), metabolic (obesity, diabetes mellitus and cardiovascular 
risk), and psychological (mood disorders and decreased quality of life) components 
[142]. Several studies undertaken still fail to unravel the pathophysiology of PCOS 
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with theories attributing the clinical phenomenon to oxidative stress, inflamma-
tion, endothelial injury and genetic mechanisms. Markers of OS are considerably 
elevated in patients with PCOS and are assumed to play significant role in its 
pathogenesis [143]. NAC (N-acetyl-cysteine) is an antioxidant which can influence 
insulin receptor activity and its secretion [144] and also has negative effects on 
apoptotic activity and can lower homocysteine levels [145]. NAC has shown favour-
able effects on ovulation induction in PCOS women and can be used as an adjuvant 
to drugs for ovulation induction [146].
4.7 Diabetes in pregnancy
Gestational diabetes mellitus can pose risk for subsequent development of later-
onset DM, metabolic syndrome, and cardiovascular disease [147]. Prevalence of 
diabetes is nearly 1–14% of pregnancies [148, 149]. Diabetes is a disease condition 
that could result in production of free radicals through glucose oxidation, altera-
tions in antioxidant defence system, lipid peroxidation, non-enzymatic glycation 
of proteins and oxidative destruction of glycated proteins [150–151]. Marked 
deficiency in antioxidant activity have also been reported during the development 
of gestational diabetes [152]. Levels of antioxidants such as selenium, zinc, and 
vitamin E are reported to be reduced in GDM [152, 153]. Even adequate intake 
of antioxidants through diet improves total antioxidant status (TAS) and overall 
health condition [154].
There are several means by which elevated blood glucose levels induce excess 
production of ROS [154–156]. High glucose levels during pregnancy can also bring 
teratogenic changes in foetus through chemical modification and complex rear-
rangements of DNA. These are brought about by glycation products from elevated 
glucose levels hence reflecting the significance of genomic injury that can disturb 
embryonic development. The deficiency states of membrane lipids, changes in 
biological prostaglandin cascade and the formation of excess free radicals bring 
about dysmorphogenesis in fetus in diabetic pregnancy [157]. There is decrease 
in antioxidant defence in women with GDM due to accelerated lipid peroxidation 
causing membrane damage. Lipid peroxidation generate hydroperoxides that 
alters prostaglandin cascade of biosynthesis and may contribute to the morbidity 
by impairing the antioxidant defence system [158, 159]. GDM also induces oxida-
tive stress in the foetus. Hence Increasing antioxidant intake during pregnancy 
remains an important part of promoting health status during pregnancy. Ahmed 
M. Maged et al reported lowered use of insulin dose for control of blood sugar with 
antioxidants supplementation in women with GDM. There was markedly improved 
neonatal outcome with decrease in NICU admission and less cases with RDS [160].
4.8 Abortion
Normal early pregnancy is subject to increase in oxygen concentration with 
more chances of ROS formation. This occurs from enzymes of respiratory reactions 
where electrons leak within the mitochondria. The syncytiotrophoblast by virtue 
of its position on the villous surface is highly vulnerable to OS due to direct expo-
sure to high intervillous PO2. The syncytiotrophoblast consequently suffer loss of 
function and degeneration. The vulnerability is also high due to lower concentration 
of antioxidant enzymes in the syncytiotrophoblast when compared to other villous 
tissues during early pregnancy. Even high levels of antioxidants needed to neutral-
ize and scavenge excessive ROS in women with recurrent abortion contributes to its 
pathogenesis apart from free radicals formed during the process. Studies reported 
there is elevated levels of lipoperoxides and significantly decreased vitamin A, E, 
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and beta carotene in women with recurrent pregnancy loss thus indicating that OS 
may be implicated in the occurrence of recurrent abortion. Studies further reported 
deficient glutathione peroxidase activity in women with recurrent abortion com-
pared to non-pregnant woman or healthy pregnancies [161–163]. Even concentra-
tion of selenium in the hair samples of women with recurrent abortion were found 
to be significantly lower when compared to healthy viable pregnancies [164].
With many studies affirming OS in the pathogenesis of recurrent abortion, 
supplementation of antioxidants during pregnancy have gained importance. 
Optimum dietary intake of antioxidants like vitamins C, E, and A, lycopenes, 
selenium compounds, lipoic acid, and ubiquinones have a role in the prevention of 
cellular damage and hence in the occurrence of recurrent pregnancy loss by scav-
enging ROS. Vitamin C and E are two antioxidants most explored and suggested 
to have beneficial role in scavenging free radicals and hence reduce the effects 
of OS in women with pregnancy loss. Both vitamins have been found to increase 
in normal pregnancy and decrease in conceptions with complications implying 
their use and consumption while balancing the OS found in such circumstances. 
However, the determination of appropriate dose and type of antioxidant is essential 
to prove its favourable effects without causing any harmful effects on the mother or 
 foetus [165, 166].
5. Conclusion
Free radicals and oxidative stress are assumed to influence diverse physiological 
functions in reproduction, as well as in conditions such as infertility, endometriosis, 
PCOS, abortion, hydatidiform mole, foetal embryopathies, peripheral neuropathy 
of pregnancy and other pregnancy complications such as GDM, IUGR and pre-
eclampsia. In-vivo evaluation of oxidative stress is still not accurately possible to 
assess. With many studies reporting role of OS in the physiological processes of 
reproductive tract, the lowest essential measure of ROS for sustenance of life which 
is well tolerated need to be specified. Extensive research on the role of different 
biomarkers in predicting the effects of ROS in averting the complications discussed 
above shall prove valuable. The effects of antioxidant therapy in preventing compli-
cations in deficient and sufficient individuals is indeed subject of research.
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